Gendicine is a replication-deficient Ad expressing wild-type p53, which would reestablish expression of p53 in p53-deficient cancer cells, and Oncorine is a conditionally replicating Ad deleted of the E1B-55kD, which may also show specificity for cancers deficient in p53 [15,51]. The gene discussed is TP53; the disease is cancer.